(MXL) MaxLinear - NASDAQ
Sector: Technology | Industry: Semiconductors | Exchange: NASDAQ (USA) | Market Cap: 7.948m USD | Total Return: 577% in 12m
Avg Turnover: 359M
Qual. Beats: 1
Rev. Trend: -69.9%
Qual. Beats: 0
Warnings
Interest Coverage Ratio -10.3 is critical
Altman Z'' -0.76 < 1.0 - financial distress zone
Tailwinds
Rs Leader, Idiosyncratic Leader, Confidence, Tailwind, Pullback 52w
MaxLinear, Inc. (MXL) designs and supplies highly integrated systems-on-chip (SoC) solutions utilized in broadband, mobile infrastructure, and industrial markets. The company’s technology portfolio combines radio frequency, analog, mixed-signal, and digital signal processing to facilitate high-speed data transmission across 5G networks, optical transceivers, and home gateways.
Operating as a fabless semiconductor company, MaxLinear focuses on research and design while outsourcing the capital-intensive manufacturing of its silicon wafers to third-party foundries. This business model allows the firm to maintain lower fixed costs and pivot quickly to emerging standards like WiFi 7 and DOCSIS 4.0. The semiconductor sector remains highly cyclical and sensitive to global supply chain fluctuations and capital expenditure cycles in telecommunications.
Investors can further evaluate these industry cycles and valuation metrics by visiting ValueRay. MaxLinear reaches its global customer base, including original equipment manufacturers and module makers, through a combination of a direct sales force and international distributors.
- Inventory correction in broadband and connectivity markets pressures short-term revenue growth
- Transition to 5G infrastructure and backhaul drives long-term infrastructure segment expansion
- Demand for high-speed optical transceivers accelerates data center and enterprise growth
- High concentration of revenue from Asian manufacturing hubs elevates geopolitical risk
- Integration of power management products improves cross-selling opportunities and gross margins
| Net Income: -132.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 11.14 > 1.0 |
| NWC/Revenue: 20.20% < 20% (prev 34.20%; Δ -14.00% < -1%) |
| CFO/TA 0.03 > 3% & CFO 22.1m > Net Income -132.1m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.6m) vs 12m ago 2.73% < -2% |
| Gross Margin: 56.97% > 18% (prev 54.54%; Δ 2.44% > 0.5%) |
| Asset Turnover: 62.57% > 50% (prev 42.23%; Δ 20.34% > 0%) |
| Interest Coverage Ratio: -10.34 > 6 (EBIT TTM -100.8m / Interest Expense TTM 9.75m) |
| A: 0.13 (Total Current Assets 249.4m - Total Current Liabilities 146.7m) / Total Assets 771.3m |
| B: -0.71 (Retained Earnings -545.5m / Total Assets 771.3m) |
| C: -0.12 (EBIT TTM -100.8m / Avg Total Assets 813.3m) |
| D: 1.43 (Book Value of Equity 454.2m / Total Liabilities 317.1m) |
| Altman-Z'' = -0.76 = CCC |
| DSRI: 0.29 (Receivables 40.9m/98.9m, Revenue 508.9m/361.2m) |
| GMI: 0.96 (GM 54.54% / 56.97%) |
| AQI: 1.09 (AQ_t 0.59 / AQ_t-1 0.54) |
| SGI: 1.41 (Revenue 508.9m / 361.2m) |
| TATA: -0.20 (NI -132.1m - CFO 22.1m) / TA 771.3m) |
| Beneish M = -3.32 (Cap -4..+1) = AA |
As of June 20, 2026, the stock is trading at USD 88.76 with a total of 4,484,700 shares traded.
Over the past week, the price has changed by +9.46%,
over one month by +1.49%,
over three months by +439.25% and
over the past year by +577.04%.
MaxLinear has received a consensus analysts rating of 4.18. Therefore, it is recommended to buy MXL.
- StrongBuy: 6
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 67.9 | -23.5% |
P/E Forward = 67.1141
P/S = 15.6183
P/B = 17.4955
P/EG = 0.3937
Revenue TTM = 508.9m USD
EBIT TTM = -100.8m USD
EBITDA TTM = -60.6m USD
Long Term Debt = 123.8m USD (from longTermDebt, last quarter)
Short Term Debt = 9.42m USD (from shortTermDebt, last quarter)
Debt = 178.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 27.4m
Net Debt = 116.1m USD (calculated: Debt 178.6m - CCE 62.5m)
Enterprise Value = 8.06b USD (7.95b + Debt 178.6m - CCE 62.5m)
Interest Coverage Ratio = -10.34 (Ebit TTM -100.8m / Interest Expense TTM 9.75m)
EV/FCF = 794.2x (Enterprise Value 8.06b / FCF TTM 10.2m)
FCF Yield = 0.13% (FCF TTM 10.2m / Enterprise Value 8.06b)
FCF Margin = 2.00% (FCF TTM 10.2m / Revenue TTM 508.9m)
Net Margin = -25.96% (Net Income TTM -132.1m / Revenue TTM 508.9m)
Gross Margin = 56.97% ((Revenue TTM 508.9m - Cost of Revenue TTM 219.0m) / Revenue TTM)
Gross Margin QoQ = 57.50% (prev 57.58%)
Tobins Q-Ratio = 10.46 (Enterprise Value 8.06b / Total Assets 771.3m)
Interest Expense / Debt = 5.46% (Interest Expense 9.75m / Debt 178.6m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -79.6m (EBIT -100.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.70 (Total Current Assets 249.4m / Total Current Liabilities 146.7m)
Debt / Equity = 0.39 (Debt 178.6m / totalStockholderEquity, last quarter 454.2m)
Debt / EBITDA = -1.91 (negative EBITDA) (Net Debt 116.1m / EBITDA -60.6m)
Debt / FCF = 11.43 (Net Debt 116.1m / FCF TTM 10.2m)
Total Stockholder Equity = 464.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -16.24% (Net Income -132.1m / Total Assets 771.3m)
RoE = -28.42% (Net Income TTM -132.1m / Total Stockholder Equity 464.8m)
RoCE = -17.13% (EBIT -100.8m / Capital Employed (Equity 464.8m + L.T.Debt 123.8m))
RoIC = -13.08% (negative operating profit) (NOPAT -79.6m / Invested Capital 608.6m)
WACC = 14.78% (E(7.95b)/V(8.13b) * Re(15.02%) + D(178.6m)/V(8.13b) * Rd(5.46%) * (1-Tc(0.21)))
Discount Rate = 15.02% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 100.00 | Cagr: 3.16%
[DCF] Terminal Value 56.32% ; FCFF base≈10.2m ; Y1≈10.2m ; Y5≈10.8m
[DCF] Fair Price = N/A (negative equity: EV 80.3m - Net Debt 116.1m = -35.8m; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.25 | # QB: 1
Revenue Correlation: -69.87 | Revenue CAGR: -23.30% | SUE: 0.72 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.33 | Chg30d=+0.00% | Revisions=+71% | Analysts=11
EPS next Quarter (2026-09-30): EPS=0.38 | Chg30d=+0.13% | Revisions=+71% | Analysts=11
EPS current Year (2026-12-31): EPS=1.34 | Chg30d=+0.10% | Revisions=+71% | GrowthEPS=+331.4% | GrowthRev=+40.5%
EPS next Year (2027-12-31): EPS=1.88 | Chg30d=+0.39% | Revisions=+69% | GrowthEPS=+40.2% | GrowthRev=+20.5%
[Analyst] Revisions Ratio: +71%